Alerts will be sent to your verified email
Verify EmailNone
Sahajanand Medical
|
Jagsonpal Pharma
|
Hamps Bio
|
|
---|---|---|---|
Operational Metrics
|
|||
Financials
|
|||
5 yr Average ROE
|
-1.51 % | 12.82 % | 17.75 % |
5yr average Equity Multiplier
|
1.75 | 1.29 | 2.66 |
5yr Average Asset Turnover Ratio
|
0.7 | 1.12 | 1.39 |
5yr Avg Net Profit Margin
|
2.44 % | 8.95 % | 5.48 % |
Price to Book
|
n/a | 6.41 | 0.0 |
P/E
|
n/a | 27.77 | 59.84 |
5yr Avg Cash Conversion Cycle
|
23.87 Days | -0.27 Days | 10.22 Days |
Inventory Days
|
73.07 Days | 47.66 Days | 38.15 Days |
Days Receivable
|
149.89 Days | 25.88 Days | 49.29 Days |
Days Payable
|
169.25 Days | 68.7 Days | 79.37 Days |
5yr Average Interest Coverage Ratio
|
5.4 | 56.07 | 3.3 |
5yr Avg ROCE
|
10.28 % | 17.0 % | 22.28 % |
5yr Avg Operating Profit Margin
|
14.58 % | 10.5 % | 15.08 % |
5 yr average Debt to Equity
|
0.43 | 0.02 | 1.2 |
5yr CAGR Net Profit
|
n/a | 23.34 % | 33.03 % |
5yr Average Return on Assets
|
1.59 % | 9.97 % | 7.45 % |
Shareholdings
|
|||
Promoter Holding
|
n/a | 67.78 % | 71.99 % |
Share Pledged by Promoters
|
n/a | 0.0 | 0.0 |
Change in Promoter Holding (3 Yrs)
|
n/a | -0.93 % | 0.0 |
Change in Mutual Fund Holding (3 Yrs)
|
n/a | 0.0 | 0.0 |
Sahajanand Medical
|
Jagsonpal Pharma
|
Hamps Bio
|
---|